327 related articles for article (PubMed ID: 9570338)
21. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the oral bioavailability of phenytoin by N-acetylation and absorptive characteristics.
Ogiso T; Tanino T; Kawaratani D; Iwaki M; Tanabe G; Muraoka O
Biol Pharm Bull; 1998 Oct; 21(10):1084-9. PubMed ID: 9821815
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the Oral Absorption of Ester-type Prodrugs].
Ohura K
Yakugaku Zasshi; 2020; 140(3):369-376. PubMed ID: 32115554
[TBL] [Abstract][Full Text] [Related]
24. Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity.
Ohura K; Sakamoto H; Ninomiya S; Imai T
Drug Metab Dispos; 2010 Feb; 38(2):323-31. PubMed ID: 19923255
[TBL] [Abstract][Full Text] [Related]
25. Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum.
Masaki K; Hashimoto M; Imai T
Drug Metab Dispos; 2007 Jul; 35(7):1089-95. PubMed ID: 17392394
[TBL] [Abstract][Full Text] [Related]
26. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
27. Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats.
Al Shaker HA; Qinna NA; Badr M; Al Omari MMH; Idkaidek N; Matalka KZ; Badwan AA
Eur J Pharm Sci; 2017 Jul; 105():137-143. PubMed ID: 28502673
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs.
Udata C; Tirucherai G; Mitra AK
J Pharm Sci; 1999 May; 88(5):544-50. PubMed ID: 10229647
[TBL] [Abstract][Full Text] [Related]
29. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
30. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
31. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in rat tissue homogenates.
Takahashi K; Tamagawa S; Haginaka J; Yasuda H; Katagi T; Mizuno N
J Pharm Sci; 1992 Mar; 81(3):226-7. PubMed ID: 1640358
[TBL] [Abstract][Full Text] [Related]
32. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
Ahmed S; Imai T; Otagiri M
Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat.
Fukuhara A; Imai T; Otagiri M
Chirality; 1996; 8(7):494-502. PubMed ID: 8970747
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
[TBL] [Abstract][Full Text] [Related]
35. Prodrugs of BMS-183920: metabolism and permeability considerations.
Obermeier MT; Chong S; Dando SA; Marino AM; Ryono DE; Starrett-Arroyo A; DiDonato GC; Warrack BM; White RE; Morrison RA
J Pharm Sci; 1996 Aug; 85(8):828-33. PubMed ID: 8863272
[TBL] [Abstract][Full Text] [Related]
36. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
Nishimuta H; Houston JB; Galetin A
Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of mgs0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid), a potent metabotropic glutamate receptor antagonist.
Nakamura M; Kawakita Y; Yasuhara A; Fukasawa Y; Yoshida K; Sakagami K; Nakazato A
Drug Metab Dispos; 2006 Mar; 34(3):369-74. PubMed ID: 16326817
[TBL] [Abstract][Full Text] [Related]
38. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
39. Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters.
Nomoto M; Tatebayashi T; Morita J; Suzuki H; Aizawa K; Kurosawa T; Komiya I
J Pharm Sci; 2009 Apr; 98(4):1532-44. PubMed ID: 18683862
[TBL] [Abstract][Full Text] [Related]
40. Species-dependent and site-specific intestinal metabolism of ester prodrugs.
Van Gelder J; Shafiee M; De Clercq E; Penninckx F; Van den Mooter G; Kinget R; Augustijns P
Int J Pharm; 2000 Sep; 205(1-2):93-100. PubMed ID: 11000545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
